Concepedia

Publication | Open Access

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

DOIFull Paper Access

14

Citations

16

References

2023

Year

Margaret E. Gatti‐Mays, Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić, Jason M. Redman, Houssein Abdul Sater, Charalampos S. Floudas, Nicole J. Toney,
The Oncologist

Abstract

Biweekly NHS-IL12 was well tolerated in this small phase I study. Additional studies incorporating NHS-IL12 with other immunomodulating agents are underway. (ClinicalTrials.gov Identifier: NCT01417546).

References

YearCitations

Page 1